IRIS Accounts Production v25.2.0.378 04367847 Board of Directors 1.1.24 31.12.24 31.12.24 18.9.25 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh043678472023-12-31043678472024-12-31043678472024-01-012024-12-31043678472022-12-31043678472023-01-012023-12-31043678472023-12-3104367847ns15:EnglandWales2024-01-012024-12-3104367847ns14:PoundSterling2024-01-012024-12-3104367847ns10:Director12024-01-012024-12-3104367847ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3104367847ns10:SmallEntities2024-01-012024-12-3104367847ns10:Audited2024-01-012024-12-3104367847ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3104367847ns10:FullAccounts2024-01-012024-12-3104367847ns10:OrdinaryShareClass12024-01-012024-12-3104367847ns10:Director22024-01-012024-12-3104367847ns10:Director42024-01-012024-12-3104367847ns10:CompanySecretary12024-01-012024-12-3104367847ns10:RegisteredOffice2024-01-012024-12-3104367847ns5:CurrentFinancialInstruments2024-12-3104367847ns5:CurrentFinancialInstruments2023-12-3104367847ns5:Non-currentFinancialInstruments2024-12-3104367847ns5:Non-currentFinancialInstruments2023-12-3104367847ns5:ShareCapital2024-12-3104367847ns5:ShareCapital2023-12-3104367847ns5:RetainedEarningsAccumulatedLosses2024-12-3104367847ns5:RetainedEarningsAccumulatedLosses2023-12-3104367847ns5:PlantMachinery2024-01-012024-12-3104367847ns5:FurnitureFittings2024-01-012024-12-3104367847ns5:ComputerEquipment2024-01-012024-12-3104367847ns5:PlantMachinery2023-12-3104367847ns5:FurnitureFittings2023-12-3104367847ns5:MotorVehicles2023-12-3104367847ns5:ComputerEquipment2023-12-3104367847ns5:MotorVehicles2024-01-012024-12-3104367847ns5:PlantMachinery2024-12-3104367847ns5:FurnitureFittings2024-12-3104367847ns5:MotorVehicles2024-12-3104367847ns5:ComputerEquipment2024-12-3104367847ns5:PlantMachinery2023-12-3104367847ns5:FurnitureFittings2023-12-3104367847ns5:MotorVehicles2023-12-3104367847ns5:ComputerEquipment2023-12-3104367847ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-12-3104367847ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3104367847ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-12-3104367847ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-12-3104367847ns10:OrdinaryShareClass12024-12-3104367847ns10:Director32024-01-012024-12-3104367847ns10:Director332023-12-3104367847ns10:Director332022-12-3104367847ns10:Director332024-01-012024-12-3104367847ns10:Director332023-01-012023-12-3104367847ns10:Director332024-12-3104367847ns10:Director332023-12-31
REGISTERED NUMBER: 04367847 (England and Wales)















PLASMATREAT UK LIMITED

Financial Statements for the Year Ended 31 December 2024






PLASMATREAT UK LIMITED (REGISTERED NUMBER: 04367847)

Contents of the Financial Statements
for the Year Ended 31 December 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PLASMATREAT UK LIMITED

Company Information
for the Year Ended 31 December 2024







DIRECTORS: C Buske
M C Buske
J W Fisk



SECRETARY: C Buske



REGISTERED OFFICE: Granville House
2 Tettenhall Road
Wolverhampton
West Midlands
WV1 4SB



REGISTERED NUMBER: 04367847 (England and Wales)



SENIOR STATUTORY AUDITOR: M Ashton ACA FCCA



AUDITORS: Lancaster Haskins Limited Statutory Auditor
Granville House
2 Tettenhall Road
Wolverhampton
West Midlands
WV1 4SB

PLASMATREAT UK LIMITED (REGISTERED NUMBER: 04367847)

Balance Sheet
31 December 2024

31.12.24 31.12.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 114,162 97,750

CURRENT ASSETS
Stocks 5 6,758 1,179
Debtors 6 133,384 175,044
Cash at bank 321,600 159,051
461,742 335,274
CREDITORS
Amounts falling due within one year 7 1,156,492 886,195
NET CURRENT LIABILITIES (694,750 ) (550,921 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(580,588

)

(453,171

)

CREDITORS
Amounts falling due after more than one
year

8

155,527

-
NET LIABILITIES (736,115 ) (453,171 )

CAPITAL AND RESERVES
Called up share capital 10 1,000 1,000
Retained earnings (737,115 ) (454,171 )
SHAREHOLDERS' FUNDS (736,115 ) (453,171 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 September 2025 and were signed on its behalf by:





J W Fisk - Director


PLASMATREAT UK LIMITED (REGISTERED NUMBER: 04367847)

Notes to the Financial Statements
for the Year Ended 31 December 2024


1. STATUTORY INFORMATION

Plasmatreat UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
Management is required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

There are no main areas of estimation uncertainty that may have a significant effect on the amounts recognised in the financial statements.

Turnover
Turnover represents sales of goods net of vat. Turnover is recognised when goods are delivered to the customer.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% SL/ 20%RB
Fixtures and fittings - 20% on cost
Computer equipment - 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


PLASMATREAT UK LIMITED (REGISTERED NUMBER: 04367847)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The directors plan to strengthen the company’s footprint in the UK by broadening its customer base, exploring new market opportunities, and providing robust support to both current and prospective clients. They have confirmed that the parent company loan will remain in place and will not be recalled until adequate financial resources are available to meet the obligation. Based on these strategic initiatives and positive profit forecasts, the directors are confident that there are no material uncertainties which would undermine the company’s ability to operate as a going concern.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 2 ) .

PLASMATREAT UK LIMITED (REGISTERED NUMBER: 04367847)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024


4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Motor Computer
machinery fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 January 2024 192,210 12,945 - 8,241 213,396
Additions 8,178 - 44,780 - 52,958
Disposals (6,932 ) - - - (6,932 )
At 31 December 2024 193,456 12,945 44,780 8,241 259,422
DEPRECIATION
At 1 January 2024 104,650 5,417 - 5,579 115,646
Charge for year 31,831 1,837 933 768 35,369
Eliminated on disposal (5,755 ) - - - (5,755 )
At 31 December 2024 130,726 7,254 933 6,347 145,260
NET BOOK VALUE
At 31 December 2024 62,730 5,691 43,847 1,894 114,162
At 31 December 2023 87,560 7,528 - 2,662 97,750

5. STOCKS
31.12.24 31.12.23
£    £   
Stocks 6,758 1,179

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade debtors 83,642 160,269
Other debtors 4,065 939
Prepayments and accrued income 45,677 13,836
133,384 175,044

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade creditors 8,405 4,135
Social security and other taxes 21,476 8,450
Other creditors 1,043 -
Amount due to parent undertaking 1,005,795 863,434
Directors' current accounts 279 1,224
Accruals and deferred income 119,494 8,952
1,156,492 886,195

PLASMATREAT UK LIMITED (REGISTERED NUMBER: 04367847)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.24 31.12.23
£    £   
Long term loan 155,527 -

9. FINANCIAL INSTRUMENTS

Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference shares or non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.24 31.12.23
value: £    £   
1,000 Ordinary £1 1,000 1,000

11. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was qualified on the following basis:

Basis for qualified opinion
The financial statements include a loan from a group company amounting to £155,527, which carries interest at a rate significantly below market rates. In accordance with FRS 102 Section 11, such a loan should be initially recognised at fair value, with the difference between the loan amount and its fair value recognised as a capital contribution. However, the loan has been recognised at its nominal value without discounting. Had the loan been discounted to fair value, liabilities would have been lower and equity correspondingly higher by £25,051.

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion.

M Ashton ACA FCCA (Senior Statutory Auditor)
for and on behalf of Lancaster Haskins Limited Statutory Auditor

PLASMATREAT UK LIMITED (REGISTERED NUMBER: 04367847)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024


12. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2024 and 31 December 2023:

31.12.24 31.12.23
£    £   
R D Potgieter
Balance outstanding at start of year (945 ) (5,534 )
Amounts advanced 945 6,139
Amounts repaid - (1,550 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - (945 )

13. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

14. FRC ETHICAL STANDARD - PROVISIONS AVAILABLE FOR SMALL ENTITIES

In common with many other businesses of our size and nature we use our auditors to prepare and submit returns to the tax authorities and assist with the preparation of the financial statements.

15. ULTIMATE CONTROLLING PARTY

The controlling party is Plasma Treat Finance International Gmbh & Co.

The ultimate controlling party is C Buske.

16. FINANCIAL RISK MANAGEMENT

The company has exposures to two main areas of risk; liquidity risk and customer credit exposure.

Liquidity risk
The objective of the company in managing liquidity risk is to ensure that it can meet its financial obligations as and when they fall due. The company expects to meet its financial obligations through operating cash flows. In the event that the operating cash flows would not cover all the financial obligations the company has credit facilities available.

Customer credit exposure
The company may offer credit terms to its customers which allow payment of the debt after delivery of the goods or services. The company is at risk to the extent that a customer may be unable to pay the debt on the specified due date. This risk is mitigated by strong on-going customer relationships.